Dolly Parton Tried. But Tennessee Is Squandering a

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks copytele #66208
280
Dolly Parton Tried. But Tennessee Is Squandering a Miracle.

July 19, 2021



Credit...John Seakwood/Walt Disney Television, via Getty Imag

By Margaret Renkl

Ms. Renkl is a contributing Opinion writer who covers flora, fauna, politics and culture in the American South.

July 16, 2021, 7:40 p.m. ET

NASHVILLE — When Dolly Parton received her first dose of the Moderna vaccine at Vanderbilt University, where her million-dollar donation helped to fund the research, she sang an updated version of her iconic song “Jolene.” The tongue-in-cheek lyrics were meant to inspire people to get vaccinated:

Vaccine, vaccine, vaccine, vaccine
I’m begging of you, please don’t hesitate
Vaccine, vaccine, vaccine, vaccine
’Cause once you’re dead, then that’s a bit too late

Trumpanzees, Trumpanzees, Trumpanzees vaccinate
I'm begging you, please don't hesitate
Trumpanzees, Trumpanzees, Trumpanzees puleeze vaccinate
'Cause one you're dead then owning the libs, yeah, that's a bit too late......

…..would've changed outcomes not a whit, but more fun doling out some deserved shit. Alas, now the hollers will be filled with long haulers.


She gave it a good try, a heroic try, but somehow the bonehead politicians running this state managed to overcome even the good will generated by its favorite daughter.

Remember how hopeful we were when the new Covid-19 vaccines arrived so astonishingly quickly, and were so astonishingly effective and safe? As a nation — politically, institutionally, too often personally — we’d botched almost everything about this pandemic, and we did not deserve a miracle. The miracle arrived anyway.

We were giddy about the prospect of those vaccines. We could not stop talking about how happy we would be to sit in a movie theater again, to hear live music again, to go to church and sing out loud again, to sit and talk around a table again, late into the night, with no care for how long we had been breathing the same air. We would reach for new babies and lean down to smell their downy heads. We would weep with the joy of being skin to skin with new life. New life, after such a long, dark year!

The anticipation of happiness seemed truly ecumenical. Liberals, conservatives, politically indifferent people — all the people I knew were watching for their vaccine priority number to come up. We were signing up for leftover doses that might be available at the end of the day. We were heading out of town to get vaccinated in rural counties where health officials were moving more quickly through the vaccine priority rankings. The lack of vaccine lines should have told us something was happening in those counties, something besides the fact that fewer people lived there.

Tennessee’s governor, Bill Lee, understood what was going on. Mr. Lee is vaccinated, but he refused to be photographed getting the shot — the Covid shot, that is: He did post a photo of himself getting a flu shot last November. “Getting a flu shot is more important than ever this year,” his Twitter post read. “I got mine to help protect my granddaughters as we prepare to celebrate their first birthday.” Not a word about protecting children from the deadliest pandemic in a hundred years.

None of this was surprising. Mr. Lee is not a leader who actually leads so much as a politician who reads the room.
From the beginning, white people in rural Tennessee have been so skeptical of this vaccine that last month state officials returned an allotment of three million doses to the federal stockpile. “We’re sort of grinding to a halt,” the state’s health commissioner, Dr. Lisa Piercey, told News Channel 5 in Nashville. “The people who want it have gotten it.”

The trouble is that not enough people want it, particularly here in the South, which accounts for eight of the 10 states with the lowest vaccination rates, and infections have begun to climb.

“The rate of daily coronavirus infections in Tennessee has more than tripled in the past three weeks — one of the largest increases in the entire nation — as the virus shows signs of renewed spread,” wrote The Tennessean’s indefatigable health reporter Brett Kelman last week. “The state’s average test positivity rate and count of active infections also climbed sharply in the same time period.”

Conservative Tennessee legislators responded, it’s true, but not by working to reduce vaccine hesitancy. Instead, they pressured state health officials to cancel vaccination events aimed at teenagers and retract social media posts urging adolescents to get vaccinated. Worse, these anti-vaccination efforts weren’t limited to the Covid-19 vaccine. Conservative lawmakers also urged the Tennessee Department of Health to halt outreach efforts designed to inform teenagers about all vaccines.

Worse still, they arranged the firing of Dr. Michelle Fiscus. As medical director of the vaccine-preventable diseases and immunization program at the Department of Health, Dr. Fiscus was the state’s top vaccine authority. “It was my job to provide evidence-based education and vaccine access so that Tennesseans could protect themselves against Covid-19,” she wrote in a statement. “I have been terminated for doing my job because some of our politicians have bought into the anti-vaccine misinformation campaign rather than taking the time to speak with the medical experts.”

The politicization of public discourse around immunization is not unique to Tennessee. The question isn’t why Tennessee is so out of step with science. The question is why politics has anything to do with health policy at all.

The planet is growing more crowded, bringing people into closer contact with diverse animal and human populations. At the same time, the health risks associated with climate change are ratcheting upward.

But just as protection against communicable diseases becomes increasingly urgent, conservative media outlets are sowing doubt and delusion in the Republican base, and feckless elected officials are following suit.

Like Mr. Lee, his licked finger held aloft in the wind of rural white discontent, other Republican leaders in the South take their lifesaving vaccines in private and give lip service to perverse notions of “freedom” in their public statements.

Campaign funding from the national oligarchs is what sets legislative agendas across the red states, so I can understand why these penny-ante politicians are working so hard to limit tax-funded safety nets. I can even understand why they’re so hellbent on killing public education.

It clearly benefits the wealthy for taxes to be low or nonexistent and for poor people to be incurious and compliant. But how can it possibly benefit the oligarchs to risk the lives of the very people who keep electing their toadies to statehouses in the first place? I just don’t get it.

“I am afraid for my state,” Dr. Fiscus wrote. I am afraid for my state, too. More than that, I’m afraid for my country. Tech companies won’t stop the spread of misinformation about vaccines, and conservative leaders can’t muster the political will to combat that misinformation with science.

I’m not saying all is lost. Even in Tennessee, 43 percent of the population has received at least one dose of a Covid vaccine, and 38 percent are fully vaccinated. People are hugging one another and kissing babies again, but people are also continuing to die for no good reason.

Their stubborn refusal to take a lifesaving vaccine is more than a pity, and it’s more than a waste. It’s a tragedy, a sign that we have squandered our miracle. I have no faith that we will be given another.

https://www.nytimes.com/2021/07/19/opinion/te...e9f650852d
Scroll down for more posts ▼

Top 10 Most Recent News Articles

XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 2

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 1

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
53% of European Telecom Users Eye Provider Switch

Updated Category News Views 2

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 5

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading
BYD's Chip Mastery Amid China's Auto Supply Tensions

Updated Category News Views 2

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health

Updated Category News Views 4

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 5

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Early Algebra: Paving the Path for Future Learning

Updated Category News Views 131

Transforming Early Algebra Education The push to teach algebra to younger students is picking up steam as researchers examine its potential to lay the groundwork for lifelong learning. A recent initiative, backed by the National Science Foundation and led by TERC, highlights the importance of early algebra education for students in grades K-2. This innovative study is set...

Continue Reading
Bouncing Back: Belgium's Stock Market Soars with BEL 20 Gains

Updated Category News Views 174

Belgium Stock Market Shows Positive Momentum The Belgian stock market ended on a high note recently, showcasing an impressive surge attributed to strong performances in several key sectors. The closing session reflected substantial gains that set a positive tone for investors. Healthcare, Industrials, and Basic Materials Lead the Charge Gains across the Healthcare,...

Continue Reading
Celebrate Tax Day with Sweet Treats from Great American Cookies

Updated Category News Views 210

Great American Cookies Sweetens Tax Day for Fans Great American Cookies, a beloved name in the cookie industry and part of FAT Brands Inc., is making Tax Day a delightful occasion for cookie lovers everywhere. With its iconic Chocolate Chip Cookie Cake, the franchise invites fans to enjoy its special buy one, get one free offer. This sweet gesture is set for April 15,...

Continue Reading
Key Insights for Investors in Replimune Group, Inc. Today

Updated Category News Views 123

Updates on Replimune Group, Inc. (NASDAQ: REPL) Replimune Group, Inc. is gaining attention within the investment community due to recent developments regarding its stock performance and the related legal implications. The company is known for its innovative cancer treatment, particularly its lead drug candidate, RP1, which is designed for advanced melanoma treatment....

Continue Reading
July Housing Market Insights in New York State

Updated Category News Views 93

Overview of the Housing Market in New York State Recent reports show that New York State's housing market is experiencing positive developments. In July, both home sales and new listings saw an increase, alongside a notable drop in mortgage interest rates. Sales Trends in July In July, closed home sales rose by 3.5 percent, jumping from 9,584 units in 2023 to 9,923 homes...

Continue Reading